CBAY

Cymabay Therapeutics
CBAY

Overview Fund Trends Analyst Outlook Journalist POV
Delisted

CBAY was delisted on the 21st of March, 2024.

Back to rankings

17 hedge funds and large institutions have $33.9M invested in Cymabay Therapeutics in 2014 Q3 according to their latest regulatory filings, with 17 funds opening new positions, increasing their positions, reducing their positions, and closing their positions.

New
Increased
Maintained
Reduced
Closed
Holders
17
Holders Change
Holders Change %
% of All Funds
Holding in Top 10
–
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
Increased
Reduced
Closed
Calls
–
Puts
–
Net Calls
Net Calls Change

Top Buyers

1
+$8.55M
2
+$6.84M
3
+$4.85M
4
DM
Deerfield Management
New York
+$3.51M
5
SFM
Sphera Funds Management
Israel
+$3.35M

Top Sellers

No sellers this quarter
Name Holding Trade Value Shares
Change 		Change in
Stake
1
$8.55M
2
$6.84M
3
$4.85M
4
$3.51M
5
$3.35M
6
$2.05M
7
$1.93M
8
$1.61M
9
$855K
10
$171K
11
$137K
12
$14K
13
$12K
14
$2K
15
$1.71K